الفهرس 
Treatment outcomes of diffuse large B-cell non-Hodgkin,s lymphoma presenting to Tanta cancer center
CONTENTSOnly 14 pages are availabe for public view
 |  | from | 183 |  |  |
| | | from | 183 | | |
Abstract
Introduction: DLBC-NHL is the most common lymphoid neoplasm and constitutes almost 50% of all NHLs. Methods: This thesis includes 485 patients was conducted to study the outcomes in patients with DLBC-NHL among patients treated at Tanta Cancer Center (TCC) between 2003 and 2006 and followed up till March 2014. Results: 88% of patients received CTx being CHOP in 72.4% of cases. CR was achieved in 62.1%, PFS was 21.4 months. The median OS was 20 months. Conclusions: Outcomes of DBLC-NHL at TCC is comparable to those in the literature. Adding Rituximab is recommended to further improve the treatment